Climb Bio: Funding, Investors & Team (Sep 2026)
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Climb Bio has raised $110M across 1 funding round on record, the most recent an undisclosed round of $110M announced in Apr 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Climb Bio Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Climb Bio Funding Rounds
Climb Bio Founders and Leadership Team
No contact details are on record for this team yet.
Climb Bio Funding Compared to Other Biotechnology Startups
Climb Bio's latest round of $110M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Climb Bio in Biotechnology and Redmond
Companies Similar to Climb Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Climb Bio Funding FAQs
What does Climb Bio do?
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
How much funding has Climb Bio raised?
Climb Bio has raised $110M across 1 round on record. The most recent is an undisclosed round of $110M announced in Apr 2026.
When did Climb Bio last raise funding?
Climb Bio's most recent funding round on record is an undisclosed round of $110M, announced in Apr 2026.
Who founded Climb Bio?
FundedIQ lists Aoife Brennan (Founder) at Climb Bio.
Where is Climb Bio headquartered?
Climb Bio is based in Redmond, Washington, United States.
How many employees does Climb Bio have?
Climb Bio is in the 11-50 employee band.
How does Climb Bio's funding compare to other Biotechnology startups?
Climb Bio's latest round of $110M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Climb Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Climb Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.